Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Treadwell Therapeutics steps to series B round

Sino Biopharmaceutical co-led the oncology treatment developer's latest round, in which it raised over $91m in funding.


Nov 23, 2021

Ultraleap captures $81m in series D funding

IP Group returned for the Bristol spinout's series D that will go to product development and commercialisation.

Nov 23, 2021

Chroma colours in $125m series A

Bringing together researchers from Italy and the US, Chroma Medicine has emerged out of stealth with series A financing led by Cormorant Asset Management.

Nov 23, 2021

Cala Health modulates $77m in funding

The neuromodulation-focused Stanford spinout increased its overall funding to $145m in a round led by Ascension Ventures.

Nov 18, 2021

Color covers $100m in funding round

Kindred Ventures led the healthcare services provider's series E round, valuing it at $4.6bn.

Nov 15, 2021

Coinbase acquires Agara

UTEC is celebrating an exit as Agara is acquired by Coinbase for a reported $40m to $50m.

Nov 11, 2021

Blade to get a slice of Nasdaq action

Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.

Nov 11, 2021

Daily deal net: November 11, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nov 11, 2021

Entrada Therapeutics enters Nasdaq

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Nov 11, 2021

Autobrains authorises $101m series C round

BMW, Continental, Knorr-Bremse and VinFast backed the autonomous perception technology developer, which traces its roots to Technion.

Nov 11, 2021

Alchemy manifests $250m in funding

The Stanford-backed blockchain development platform increased its valuation to $3.5bn in the series C round.

Nov 11, 2021

Egle Therapeutics lands series A funding

Takeda Ventures was among the participants in a $46.5m round closed nearly a year after its parent company launched a partnership with the Institut Curie spinout.

Nov 11, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here